Merck Consolidated Statement of Comprehensive Income Audited

Profit after tax

579.0

618.0¹

Available-for-sale financial assets

 Fair value adjustments

0.4

26.5

 Reclassification to income statement

–

–24.2

 Deferred taxes

[34]

–

1.6

 Changes recognized in equity

0.4

3.9

Derivative financial instruments

 Fair value adjustments

3.6

–50.1

 Reclassification to income statement

78.4

12.3

 Reclassification to assets

–

–

 Deferred taxes

[34]

–16.9

4.3

 Changes recognized in equity

65.1

–33.5

Remeasurement of the net defined benefit liability

 Changes in remeasurement

[51]

–304.3

–20.2¹

 Deferred taxes

[34]

37.2

7.0¹

 Changes recognized in equity

–267.1

–13.2¹

Exchange differences on translating foreign operations

Changes taken directly to equity

–34.6

–47.9

Reclassification to income statement

–

3.5

Changes recognized in equity

–34.6

–44.4

Gains / losses recognized immediately in equity

–236.2

–87.2¹

Comprehensive income

342.8

530.8¹

of which attributable to Merck KGaA shareholders

333.7

523.2¹

of which attributable to non-controlling interest

9.1

7.6